|
2023
|
Invention
|
Methods for treatment of bone marrow failure and related conditions. in vivoex vivoex vivo with a... |
|
|
Invention
|
Kdm1a inhibitors for the treatment of disease. Disclosed herein are new compounds and composition... |
|
|
Invention
|
Methods for the enhancement of therapeutic effect of car-t cells.
Provided herein is the use of ... |
|
|
Invention
|
Methods for the enhancement of therapeutic effect of car-t cells. Provided herein is the use of L... |
|
|
Invention
|
Pharmaceutical formulations for treating diseases mediated by kdm1a.
Provided is a pharmaceutica... |
|
2022
|
Invention
|
Kdm1a inhibitors for the treatment of disease. The present disclosure relates to compounds and me... |
|
|
Invention
|
Kdm1a inhibitors for the treatment of disease.
Disclosed herein are new compounds and compositio... |
|
|
Invention
|
Methods and processes for the preparation of kdm1a inhibitors.
Provided in this disclosure are m... |
|
|
Invention
|
Lysine-specific histone demethylase inhibitors for the treatment of myeloproliferative neoplasms.... |
|
2021
|
P/S
|
Pharmaceutical preparations for the treatment of genetic diseases that involve dysregulation of e... |
|
|
Invention
|
Pharmaceutical formulations for treating diseases mediated by kdm1a. N-((RSHH-1,2,3-triazol-1-yl)... |
|
|
Invention
|
Lysine-specific histone demethylase as a novel therapeutic target in myeloproliferative neoplasms... |
|
2017
|
Invention
|
Compositions and methods for producing stereoisomerically pure aminocyclopropanes.
The present d... |
|
|
Invention
|
Methods and processes for the preparation of kdm1a inhibitors. Provided in this disclosure are me... |
|
|
Invention
|
Compositions and methods for producing stereoisomerically pure aminocyclopropanes. The present di... |
|
2014
|
P/S
|
Pharmaceutical research and development |
